Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
InnoPath Therapeutics
Sherman Oaks, California, United States
- Ownership
- Private
- Employees
- ~4
- Development stage
- Other
01
Overview
InnoPath Therapeutics is developing a portfolio of first-in-class topical therapeutics for actinic keratoses and non-melanoma skin cancers. Their lead compound, INP-08, is in pre-clinical development with animal proof-of-concept studies underway. The company has filed five patents and expects to reach Phase II within five years. No clinical results are available yet as all programs are pre-clinical.
- Therapeutic areas
- OncologyDermatology
- Modalities
- Small moleculeTopical therapeutic
- Industry
- Biotech
02
Partnerships
No major pharmaceutical or biotech partnerships publicly disclosed as of June 2025.
Beyond the preview
Go deeper on InnoPath Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on InnoPath Therapeutics.